- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04201717
Total Laparoscopic Versus Laparoscopic Assisted Left-sided Colon Cancer Resection
September 20, 2020 updated by: Dong Yang, Jilin University
Total Laparoscopic Versus Laparoscopic Assisted Left-sided Colon Cancer Resection:A Prospective, Multicenter, Randomized Controlled, Non Inferior Clinical Trial
The comparison between total laparoscopic and laparoscopic assisted left hemicolon cancer resection underwent to choose a more effective and safe operation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a prospective randomized controlled trial.
It is estimated that the recruitment time is 24 months and the number of cases is 354 in total.
The cases in the experimental group and the control group are allocated according to the proportion of 1:1.
The perioperative recovery data, complications and oncology index of total laparoscopic and laparoscopic assisted operation would be compared.
Study Type
Interventional
Enrollment (Anticipated)
354
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dong Yang, doctor
Study Locations
-
-
Ji Lin
-
Changchun, Ji Lin, China, 130021
- Recruiting
- The First Hospital of Jilin University
-
Contact:
- Quan Wang, Professor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- left sided cancer was defined as a tumour located in the distal third of transverse colon, in the left colonic angle, in the proximal descending colon, or the upper sigmoid colon(cT1-cT4a).
- underwent total laparoscopic or laparoscopic assisted left-sided cancer resection
Exclusion Criteria:
have simultaneously other cancer
- have severe systemic inflammatory disease ,serious illness such as diabetes, chronic lung diseases
- the period is too late or the tumor is too large to carry on a total laparoscopic or laparoscopic assisted left-sided cancer resection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: laparoscopic assisted left colectomy
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard.
lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion.
The patients in the control group underwent with the traditional laparoscopic assisted technology.
The free colon was taken out through a small incision in the middle of the abdomen or the outer edge of the left rectus abdominis.
The mesentery was trimmed, the specimens were removed, and the anastomosis was completed.After the anastomosis, the whole surgical area was flushed and drainage tubes were left.
|
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard.
lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion.
The patients in the control group underwent with the traditional laparoscopic assisted technology.
The free colon was taken out through a small incision in the middle of the abdomen or the outer edge of the left rectus abdominis.
The mesentery was trimmed, the specimens were removed, and the anastomosis was completed.
After the anastomosis, the whole surgical area was flushed and drainage tubes were left.
|
Experimental: total laparoscopic left colectomy
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard.
lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion.In the experimental group, the mesentery was endoscopically trimmed, the specimens were excised and the anastomosis was completed under the laparoscope.
The specimens were taken out through trocar incision in the navel or in the right lower abdomen.
After the anastomosis, the whole surgical area was flushed and drainage tubes were left.
|
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard.
lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion.
In the experimental group, the mesentery was endoscopically trimmed, the specimens were excised and the anastomosis was completed under the laparoscope.
The specimens were taken out through trocar incision in the navel or in the right lower abdomen.
After the anastomosis, all surgical area was flushed and drainage tubes were left.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
surgical site infection,SSI
Time Frame: one month after surgery
|
The primary outcome was the incidence of SSI based on the definitions of CDC guidelines: superficial incisional, deep incisional, and organ/space infections .
Infections involving both organ/space and the incisional site (superficial or deep) were categorized as organ/space infections.
Surgeons and nurses assessed the presence of infection daily during hospitalization.
After hospital discharge, all patients were followed up until 30 days after surgery at outpatient clinics to check the wound.
|
one month after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the blood loss
Time Frame: one hour after surgery
|
the mount of blood loss during the whole operation
|
one hour after surgery
|
the operating time
Time Frame: one hour after surgery
|
the length between the beginning and the end of the whole operation
|
one hour after surgery
|
the incidence of complications
Time Frame: one month after surgery
|
one month after surgery
|
|
the conversive rate
Time Frame: one hour after surgery
|
one hour after surgery
|
|
Surgical resection quality
Time Frame: one hour after surgery
|
according to the CME (complete mesocolic excision,CME) evaluation criteria
|
one hour after surgery
|
number of lymphnodes dissected
Time Frame: one week after surgery
|
one week after surgery
|
|
first defecation time
Time Frame: one week after surgery
|
one week after surgery
|
|
the incision length
Time Frame: one week after surgery
|
one week after surgery
|
|
Visual Analogue Scale/Score (VAS)
Time Frame: one day after surgery
|
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.For example, the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain ( from 0 to 10)
|
one day after surgery
|
3-year DFS (Disease-free survival)
Time Frame: three years after the operation
|
three years after the operation
|
|
5-year OS (overall survival)
Time Frame: five years after the operation
|
five years after the operation
|
|
first time for fluid diet
Time Frame: one week after surgery
|
one week after surgery
|
|
hospital stay
Time Frame: one month after surgery
|
one month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 12, 2020
Primary Completion (Anticipated)
December 20, 2021
Study Completion (Anticipated)
December 20, 2026
Study Registration Dates
First Submitted
December 12, 2019
First Submitted That Met QC Criteria
December 14, 2019
First Posted (Actual)
December 17, 2019
Study Record Updates
Last Update Posted (Actual)
September 22, 2020
Last Update Submitted That Met QC Criteria
September 20, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 130023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Cancer
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
Gruppo Oncologico del Nord-OvestSeagen Inc.; Servier; Foundation MedicineRecruitingStage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon CancerItaly
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Depressive Symptoms | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Psychosocial Effects of Cancer and Its Treatment | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage I Colon Cancer | Stage... and other conditionsUnited States
-
Hospital da Senhora da OliveiraCompletedColon Cancer | Colon Adenoma | Colon Polyp | Colon Rectal CancerPortugal
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingStage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | Microsatellite Stable Colon Carcinoma | Stage IIB Colon Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8United States
-
National Cancer Institute (NCI)CompletedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
Howard S. Hochster, MDRecruitingStage IV Colon Cancer AJCC v8 | Stage IVA Colon Cancer AJCC v8 | Stage IVB Colon Cancer AJCC v8 | Stage IVC Colon Cancer AJCC v8 | Metastatic Colon CarcinomaUnited States
-
NorgineXolomon Tree S.L.CompletedColon Cancer | Colon Disease | Colon CleansingSpain, Portugal
Clinical Trials on laparoscopic assisted left colectomy
-
S.M. Misericordia HospitalRecruitingDiverticulitis | Diverticular DiseasesItaly
-
The Queen Elizabeth HospitalNational Health and Medical Research Council, Australia; Ethicon Endo-Surgery; Health Research Council, New ZealandUnknownColonic NeoplasmsAustralia, New Zealand
-
University of Southern DenmarkRegion of Southern DenmarkNot yet recruitingSystemic Inflammatory Response Syndrome | Inflammation | Colon Cancer | Colonic Neoplasms | Laparoscopy | Robotic Surgical Procedures | Peritoneal InflammationDenmark
-
G. Hatzikosta General HospitalUniversity of IoanninaCompletedColorectal Cancer | Oxidative Stress | Colon Rectal ResectionGreece
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Taipei Medical University Shuang Ho HospitalCompletedAnastomosis, FunctionalTaiwan
-
University Hospital, MontpellierDepartment of Visceral and Digestive Surgery, Centre hospitalier de DunkerqueCompletedLeft Elective Colectomy | Renal Transplanted PatientsFrance
-
University of ZurichCompleted
-
Pamela Youde Nethersole Eastern HospitalCompletedPostoperative Wound Complication | Pain,China
-
Vejle HospitalRecruitingColorectal CancerDenmark